Zohar J, Westenberg H G
Tel-Aviv University, Herzlia, Israel.
Acta Psychiatr Scand Suppl. 2000;403:39-49. doi: 10.1111/j.1600-0447.2000.tb10947.x.
Anxiety disorders are the most common mental health disorders. While the older tricylic antidepressants (TCAs) are efficacious in the treatment of many anxiety disorders, recent studies with fluoxetine and other selective serotonin reuptake inhibitors (SSRIs) have emphasized the role of serotonin in the aetiology of these conditions.
We reviewed the efficacy, safety and tolerability of TCAs and SSRIs in the treatment of the most common anxiety disorders, specifically, panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, social phobia and generalized anxiety disorder.
Both the TCA and SSRI antidepressants are effective in treating a wide variety of anxiety disorders. SSRIs, due to their greater safety and tolerability, should be the preferred choices in treating anxiety disorders in those instances where TCAs and SSRIs are considered equally effective. In the cases of OCD and social phobia, SSRIs are almost always preferable given that the TCAs do not appear effective in these disorders.
Further research is needed on the naturalistic long-term use of the TCAs and SSRIs in the treatment of anxiety disorders.
焦虑症是最常见的心理健康障碍。虽然较老的三环类抗抑郁药(TCA)对多种焦虑症有效,但最近关于氟西汀和其他选择性5-羟色胺再摄取抑制剂(SSRI)的研究强调了5-羟色胺在这些病症病因中的作用。
我们回顾了TCA和SSRI在治疗最常见焦虑症中的疗效、安全性和耐受性,特别是惊恐障碍、强迫症、创伤后应激障碍、社交恐惧症和广泛性焦虑症。
TCA和SSRI抗抑郁药在治疗多种焦虑症方面均有效。由于SSRI具有更高的安全性和耐受性,在认为TCA和SSRI同样有效的情况下,SSRI应是治疗焦虑症的首选。在强迫症和社交恐惧症的情况下,鉴于TCA在这些病症中似乎无效,SSRI几乎总是更可取的。
需要进一步研究TCA和SSRI在焦虑症治疗中的自然长期使用情况。